BGUUF yields 2222.22% · PFE yields 6.13%● Live data
📍 BGUUF pulled ahead of the other in Year 1
Combined, BGUUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BGUUF + PFE for your $10,000?
Benguet Corporation, together with its subsidiaries, engages in the exploration, research and development, and production of gold, nickel, lime, and other metallic and nonmetallic mineral projects in the Philippines. It operates through four segments: Mining, Health Services, Logistics, and Others. The company holds interests in the Ampucao Copper-Gold, Pantingan Copper-Gold, Zamboanga Gold, Surigao Coal, and Ilocos Norte and Apayao FTAA prospects in the Philippines. It also develops and sells subdivision lots; trades in construction supplies; and sells water. In addition, the company offers healthcare and diagnostic services; port and shipping, and trucking services; and logistics services to the supply-chain requirements of various industries. Further, it engages in the research, development, real estate, and water projects. The company was incorporated in 1903 and is headquartered in Makati City, the Philippines.
Full BGUUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.